Clinical Trial Update: Safety and Efficacy Study of Amniotic Membrane Patch to Treat Postoperative Atrial Fibrillation [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial evaluating an amniotic membrane patch for postoperative atrial fibrillation has been withdrawn (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Amniotic Membrane Patch (amniotic membrane patch)

Snippet

Sponsor: University of Arizona | Conditions: Atrial Fibrillation | Phase 1, Phase 2 | Status: WITHDRAWN